Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosalind Smyth

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the Royal Society of Medicine|August 25, 2006
Cochrane systematic reviews in cystic fibrosisRosalind Smyth, Nicola Jahnke
Journal of Evaluation in Clinical Practice|June 11, 2004
Adjusting for publication bias: modelling the selection processCarrol Preston, Deborah Ashby, Rosalind Smyth
Thorax|August 7, 2019
Respiratory syncytial virus (RSV): a scourge from infancy to old ageJames Andrew Coultas, Rosalind Smyth, Peter J Openshaw
Plos One|September 7, 2013
A longitudinal study of the impact of social deprivation and disease severity on employment status in the UK cystic fibrosis populationDavid C Taylor-Robinson, Rosalind Smyth, Peter J Diggle, et al.
The European Respiratory Journal|December 19, 2015
Social inequalities in wheezing in children: findings from the UK Millennium Cohort StudyDavid C Taylor-Robinson, Anna Pearce, Margaret Whitehead, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2003
Using disease registries for pharmacoepidemiological research: a case study of data from a cystic fibrosis registryJudith Strobl, Ian Enzer, Adrian Bagust, et al.
Thorax|March 26, 2013
Author’s response: understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal studyDavid Taylor-Robinson, Margaret Whitehead, Finn Diderichsen, et al.
Plos One|March 10, 2012
Adverse drug reactions in children--a systematic reviewRebecca Mary Diane Smyth, Elizabeth Gargon, Jamie Kirkham, et al.
British Journal of Clinical Pharmacology|September 3, 2021
Access to palivizumab among children at high risk of respiratory syncytial virus complications in English hospitalsAnia Zylbersztejn, Ofran Almossawi, Nikesh Gudka, et al.
The European Respiratory Journal|September 5, 2014
Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis populationDavid C Taylor-Robinson, Karsten Thielen, Tania Pressler, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the Royal Society of Medicine|August 25, 2006
Cochrane systematic reviews in cystic fibrosisRosalind Smyth, Nicola Jahnke
Journal of Evaluation in Clinical Practice|June 11, 2004
Adjusting for publication bias: modelling the selection processCarrol Preston, Deborah Ashby, Rosalind Smyth
Thorax|August 7, 2019
Respiratory syncytial virus (RSV): a scourge from infancy to old ageJames Andrew Coultas, Rosalind Smyth, Peter J Openshaw
Plos One|September 7, 2013
A longitudinal study of the impact of social deprivation and disease severity on employment status in the UK cystic fibrosis populationDavid C Taylor-Robinson, Rosalind Smyth, Peter J Diggle, et al.
The European Respiratory Journal|December 19, 2015
Social inequalities in wheezing in children: findings from the UK Millennium Cohort StudyDavid C Taylor-Robinson, Anna Pearce, Margaret Whitehead, et al.
Pharmacoepidemiology and Drug Safety|September 30, 2003
Using disease registries for pharmacoepidemiological research: a case study of data from a cystic fibrosis registryJudith Strobl, Ian Enzer, Adrian Bagust, et al.
Thorax|March 26, 2013
Author’s response: understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal studyDavid Taylor-Robinson, Margaret Whitehead, Finn Diderichsen, et al.
Plos One|March 10, 2012
Adverse drug reactions in children--a systematic reviewRebecca Mary Diane Smyth, Elizabeth Gargon, Jamie Kirkham, et al.
British Journal of Clinical Pharmacology|September 3, 2021
Access to palivizumab among children at high risk of respiratory syncytial virus complications in English hospitalsAnia Zylbersztejn, Ofran Almossawi, Nikesh Gudka, et al.
The European Respiratory Journal|September 5, 2014
Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis populationDavid C Taylor-Robinson, Karsten Thielen, Tania Pressler, et al.
Pageof 2